Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma

IntroductionDiffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. While Metabolic Syndrome (MetS) has been linked to NHL prognosis, its impact on DLBCL outcomes remains unc...

Full description

Saved in:
Bibliographic Details
Main Authors: Dewan Zhao, He Xu, Fengrao Tang, Tongcheng Cui, Xiuli Sun, Guirong Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1524498/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items